<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2416650-A4" country="EP" doc-number="2416650" kind="A4" date="20140101" family-id="42936607" file-reference-id="316319" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146552495" ucid="EP-2416650-A4"><document-id><country>EP</country><doc-number>2416650</doc-number><kind>A4</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-10762524-A" is-representative="NO"><document-id mxw-id="PAPP154826418" load-source="docdb" format="epo"><country>EP</country><doc-number>10762524</doc-number><kind>A</kind><date>20100409</date><lang>EN</lang></document-id><document-id mxw-id="PAPP220366068" load-source="docdb" format="original"><country>EP</country><doc-number>10762524.6</doc-number><date>20100409</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140448731" ucid="US-16854009-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>16854009</doc-number><kind>P</kind><date>20090410</date></document-id></priority-claim><priority-claim mxw-id="PPC140453295" ucid="US-2010030596-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>2010030596</doc-number><kind>W</kind><date>20100409</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988130176" load-source="docdb">A61K  31/337       20060101AFI20131125BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988131693" load-source="docdb">A61K   9/14        20060101ALI20131125BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988138271" load-source="docdb">A61K   9/51        20060101ALI20131125BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1796776836" load-source="docdb" scheme="CPC">A61K   9/5169      20130101 LI20170627BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988132549" load-source="docdb" scheme="CPC">A61K   9/146       20130101 LI20130802BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988138603" load-source="docdb" scheme="CPC">A61K   9/0019      20130101 LI20131121BHEP        </classification-cpc><classification-cpc mxw-id="PCL2062875131" load-source="docdb" scheme="CPC">A61K   9/14        20130101 LI20140321BHEP        </classification-cpc><classification-cpc mxw-id="PCL2062875820" load-source="docdb" scheme="CPC">A61K  31/337       20130101 FI20140321BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132189969" lang="DE" load-source="docdb">NANOPARTIKELFORMULIERUNGEN UND IHRE VERWENDUNG</invention-title><invention-title mxw-id="PT132189970" lang="EN" load-source="docdb">NANOPARTICLE FORMULATIONS AND USES THEROF</invention-title><invention-title mxw-id="PT132189971" lang="FR" load-source="docdb">FORMULATIONS DE NANOPARTICULES ET LEURS UTILISATIONS</invention-title><citations><patent-citations><patcit mxw-id="PCIT370959977" load-source="docdb" ucid="US-20070082838-A1"><document-id format="epo"><country>US</country><doc-number>20070082838</doc-number><kind>A1</kind><date>20070412</date></document-id><sources><source name="SEA" category="XDI" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT370957725" load-source="docdb" ucid="US-6749868-B1"><document-id format="epo"><country>US</country><doc-number>6749868</doc-number><kind>B1</kind><date>20040615</date></document-id><sources><source name="SEA" category="XD" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT370958343" load-source="docdb" ucid="WO-2006089207-A2"><document-id format="epo"><country>WO</country><doc-number>2006089207</doc-number><kind>A2</kind><date>20060824</date></document-id><sources><source name="SEA" category="A" created-by-npl="N"/></sources></patcit></patent-citations><non-patent-citations><nplcit><text>F. D. KOLODGIE: "Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel", CIRCULATION, vol. 106, no. 10, 19 August 2002 (2002-08-19), pages 1195 - 1198, XP055089573, ISSN: 0009-7322, DOI: 10.1161/01.CIR.0000032141.31476.15</text><sources><source mxw-id="PNPL67315324" load-source="docdb" name="SEA" category="X"/></sources></nplcit><nplcit><text>See also references of WO 2010118365A1</text><sources><source mxw-id="PNPL67315325" load-source="docdb" name="SEA"/></sources></nplcit><nplcit><text>W. J. GRADISHAR: "Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil-Based Paclitaxel in Women With Breast Cancer", JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 31, November 2005 (2005-11-01), pages 7794 - 7803, XP055089298, ISSN: 0732-183X, DOI: 10.1200/JCO.2005.04.937</text><sources><source mxw-id="PNPL67315326" load-source="docdb" name="SEA" category="I"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR918139978" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ABRAXIS BIOSCIENCE LLC</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR918151076" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ABRAXIS BIOSCIENCE, LLC</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918137012" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>DESAI NEIL P</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918172290" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>DESAI, NEIL, P.</last-name></addressbook></inventor><inventor mxw-id="PPAR918148208" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>TAO CHUNLIN</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918152085" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>TAO, CHUNLIN</last-name></addressbook></inventor><inventor mxw-id="PPAR918173009" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>DE TAPAS</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918132636" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>DE, TAPAS</last-name></addressbook></inventor><inventor mxw-id="PPAR918134656" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>CI SHERRY XIAOPEI</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918153371" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>CI, SHERRY, XIAOPEI</last-name></addressbook></inventor><inventor mxw-id="PPAR918170754" load-source="docdb" sequence="5" format="epo"><addressbook><last-name>TRIEU VUONG</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918163166" load-source="docdb" sequence="5" format="intermediate"><addressbook><last-name>TRIEU, VUONG</last-name></addressbook></inventor></inventors></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS548961518" load-source="docdb">AT</country><country mxw-id="DS548822959" load-source="docdb">BE</country><country mxw-id="DS548950813" load-source="docdb">BG</country><country mxw-id="DS548955772" load-source="docdb">CH</country><country mxw-id="DS548875874" load-source="docdb">CY</country><country mxw-id="DS548961519" load-source="docdb">CZ</country><country mxw-id="DS548822960" load-source="docdb">DE</country><country mxw-id="DS548875875" load-source="docdb">DK</country><country mxw-id="DS548875876" load-source="docdb">EE</country><country mxw-id="DS548959921" load-source="docdb">ES</country><country mxw-id="DS548950814" load-source="docdb">FI</country><country mxw-id="DS548950815" load-source="docdb">FR</country><country mxw-id="DS548822961" load-source="docdb">GB</country><country mxw-id="DS548875877" load-source="docdb">GR</country><country mxw-id="DS548822962" load-source="docdb">HR</country><country mxw-id="DS548961520" load-source="docdb">HU</country><country mxw-id="DS548955773" load-source="docdb">IE</country><country mxw-id="DS548822963" load-source="docdb">IS</country><country mxw-id="DS548950816" load-source="docdb">IT</country><country mxw-id="DS548875882" load-source="docdb">LI</country><country mxw-id="DS548948604" load-source="docdb">LT</country><country mxw-id="DS548961521" load-source="docdb">LU</country><country mxw-id="DS548948605" load-source="docdb">LV</country><country mxw-id="DS548948606" load-source="docdb">MC</country><country mxw-id="DS548848113" load-source="docdb">MK</country><country mxw-id="DS548848114" load-source="docdb">MT</country><country mxw-id="DS548959922" load-source="docdb">NL</country><country mxw-id="DS548950817" load-source="docdb">NO</country><country mxw-id="DS548848115" load-source="docdb">PL</country><country mxw-id="DS548955774" load-source="docdb">PT</country><country mxw-id="DS548959923" load-source="docdb">RO</country><country mxw-id="DS548848116" load-source="docdb">SE</country><country mxw-id="DS548955775" load-source="docdb">SI</country><country mxw-id="DS548950818" load-source="docdb">SK</country><country mxw-id="DS548848117" load-source="docdb">SM</country><country mxw-id="DS548875883" load-source="docdb">TR</country></ep-contracting-states><ep-extended-states><ep-extended-state-data><country>AL</country></ep-extended-state-data><ep-extended-state-data><country>BA</country></ep-extended-state-data><ep-extended-state-data><country>ME</country></ep-extended-state-data><ep-extended-state-data><country>RS</country></ep-extended-state-data></ep-extended-states></designated-states></international-convention-data></bibliographic-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
